GlassScriptPhysician profile
Ritu Dutta
NPI 1093957573
$4,706.12
in general payments reported to CMS, 2019-2025
17 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $229 · 2021: $3,952 · 2023: $99.17 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $210.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,014.03 | 2021-2025 | Da Vinci Surgical System |
| Abbvie INC. | $322.04 | 2019-2021 | |
| Therapeuticsmd, INC. | $68.61 | 2019-2021 | |
| Ethicon US, LLC | $35.75 | 2019 | |
| Agile Therapeutics, INC. | $32.06 | 2021 | |
| Millicent US INC | $28.17 | 2019 | |
| Allergan, INC. | $25.05 | 2019 | |
| Acessa Health INC. | $24.45 | 2019-2020 | |
| Pfizer INC. | $23.58 | 2019 | |
| Lupin INC. | $22.05 | 2019 | |
| Astellas Pharma US INC | $21.03 | 2020 | |
| Boston Scientific Corporation | $17.73 | 2020 | |
| Merck Sharp & Dohme LLC | $17.36 | 2019 | |
| Avion Pharmaceuticals | $16.00 | 2021 | |
| Shield Therapeutics INC | $14.53 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $12.55 | 2019 | |
| Minerva Surgical, INC | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ritu Dutta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.